Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Albert Labs logo — Innovative mental health medicines for patients with unmet n...

Albert Labs

Innovative mental health medicines for patients with unmet needs

Founded 2020 United Kingdom London, United Kingdom 8 employees Post Ipo Debt Total: $830.00K Biotechnology, Health and Wellness +1

General Information

Company Name Albert Labs
Founded Year 2020
Location United Kingdom London, United Kingdom +1
Employees 8
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Post Ipo Debt
Social

Get notified when Albert Labs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Albert Labs

Albert Labs is a bio-pharmaceutical company founded in 2020 with a focus on developing innovative mental health medicines to address the unmet needs of patients. The company is pursuing licensing approval for active compounds from natural sources, aiming to provide access to effective prescription medicines for people suffering from mental health disorders. The team of drug development experts at Albert Labs leverages advanced culture technology and extraction methods to produce unique and effective natural medicines. The company's approach involves developing clinical solutions through an approved, fast track regulatory pathway with a focus on Real World Evidence (RWE) studies. This approach has been increasingly recognized as a valuable clinical access route, particularly in oncology and in the successful development of COVID-19 vaccines. Albert Labs collaborates with research institutions, hospital centers, and government agencies to utilize existing clinical infrastructure and improve patient access to treatment. Their first drug target, KRN-101, is aimed at providing a potential solution for cancer-related anxiety, addressing a market of over 15 million people with an estimated 1 million new sufferers each year. The company is headquartered in the United Kingdom and has recently secured a $830.00K Post-IPO Debt investment at 23 March 2023 from Cantheon Capital. Albert Labs operates within the Biotechnology and Pharmaceutical industries, positioning itself as a promising player in the mental health pharmaceutical sector.

Taxonomy: biopharmaceutical, mental health, drug development, clinical solutions, real world evidence, natural medicines, cancer-related anxiety, clinical infrastructure, research institutions, regulatory pathway

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1 •••• •••• 23 Mar 2023

Albert Labs Alternatives & Competitors

Albert Labs vs
Magdalena Biosciences
Magdalena Biosciences

Jaguar Health (NASDAQ: JAGX) and Filament Health joint venture focused on plant-based Rx medicines f...

Seed
3 employees
Health Care
Albert Labs vs
DevPro Biopharma
DevPro Biopharma United States

Clinical Research and Development Accelerator

21 employees
Biotechnology, Pharmaceutical
Albert Labs vs
Bionical Emas
Bionical Emas United Kingdom

Powering the patient journey

262 employees
Analytics, Health Care

FAQ About Albert Labs

Innovative mental health medicines for patients with unmet needs
Albert Labs was founded in 2020.
Albert Labs is headquartered in London, United Kingdom.
Albert Labs operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Albert Labs has approximately 8 employees.
Albert Labs has completed 1 funding round, raising a total of $830.00K. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Albert Labs include Magdalena Biosciences, DevPro Biopharma, Bionical Emas, Blueberry Therapeutics Ltd, Beckley Psytech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Albert Labs and Magdalena Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Albert Labs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy